Home
>
National Drug Code (NDC)
>
Quinapril
Quinapril - 31722-269-10 - (Quinapril)
Drug Information of Quinapril
| Product NDC: | 31722-269 |
| Proprietary Name: | Quinapril |
| Non Proprietary Name: | Quinapril |
| Active Ingredient(s): | 20 mg/1 & nbsp; Quinapril |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Quinapril
| Product NDC: | 31722-269 |
| Labeler Name: | Camber Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078457 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120120 |
Package Information of Quinapril
| Package NDC: | 31722-269-10 |
| Package Description: | 24 BOTTLE in 1 CASE (31722-269-10) > 1000 TABLET in 1 BOTTLE |
NDC Information of Quinapril
| NDC Code | 31722-269-10 |
| Proprietary Name | Quinapril |
| Package Description | 24 BOTTLE in 1 CASE (31722-269-10) > 1000 TABLET in 1 BOTTLE |
| Product NDC | 31722-269 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Quinapril |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120120 |
| Marketing Category Name | ANDA |
| Labeler Name | Camber Pharmaceuticals |
| Substance Name | QUINAPRIL HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
